Importantly, we noticed that extrinsic stimuli, such as ATR inhibitor and Topotecan, can trigger the expression of genes encoding type I IFN signaling and pro‐inflammatory cytokines/chemokines only in a subset of SCLC, providing experimental basis of refined treatment strategies for SCLC patients. The gene discussed is ATR; the disease is small cell lung carcinoma.